Sort   by:  
 Page size 
UnknownRandomized phase II, double-blind, placebo-controlled study of exemestane with or without entinostat in postmenopausal women with locally recurrent or metastatic estrogen receptor-positive breast cancer progressing on treatment with a nonsteroidal aromatase inhibitor.
Not available
S-EPMC4881332 | biostudies-literature
UnknownEnzalutamide for the Treatment of Androgen Receptor-Expressing Triple-Negative Breast Cancer.
Not available
S-EPMC5858523 | biostudies-literature
Sort   by:  
 Page size